MILES - UK: Post Marketing, Multicenter, Single Arm, Observational Clinical Registry to Evaluate Safety and Efficacy of BioMime Sirolimus Eluting Stent System In All Comers Real World Population With Coronary Artery Stenosis in United Kingdom.
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2015
Price : $35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms MILES - UK
- 28 Nov 2015 Planned number of patients changed from 120 to 700, according to United Kingdom Clinical Research Network record.
- 26 Oct 2015 Status changed from active, no longer recruiting to recruiting as reported by United Kingdom Clinical Research Network record.
- 17 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.